secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axonics, Inc. (—)
CIK:        0001603756
Form:       8-K
Filed at:   2024-11-15T23:59:59+00:00
Accession:  0001628280-24-048038
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axonics acquired by Boston Scientific for $71/share; stock delisted from Nasdaq
-------------------------------------------------------------------------------

- Merger completed Nov 15, 2024; each Axonics share converted to $71 cash; aggregate equity ~$3.7B.
- Axonics common stock suspended from trading on Nasdaq on Nov 15; Form 25 to be filed for delisting/deregistration.
- All prior directors and officers terminated; new board and officers appointed from Boston Scientific and Merger Sub.
- Charter and bylaws amended and restated; Axonics now wholly owned by Boston Scientific.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1603756/000162828024048038/0001628280-24-048038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1603756/000162828024048038/axnx-20241115.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-048038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer